Concepedia

Publication | Open Access

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer

435

Citations

18

References

2020

Year

Abstract

ClinicalTrials.gov Identifier: NCT02829918.

References

YearCitations

Page 1